When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
TORC - ResTORbio Is Trading At Less Than Half Of Its Net Cash After Crash
resTORbio Inc.
Last week I wrote an article on AnaptysBio, Inc. (NASDAQ:ANAB) after it got hammered down to over $100 million below its net cash value due to a failed clinical trial. The stock has since marginally recovered and I expect that to continue as it is still trading about $4 per share below net cash. ResTORbio, Inc. (TORC) is a biotech in a similar but even more extreme situation as ANAB after its lead candidate failed a Phase 3 clinical trial on Friday. The stock responded by tanking an outstanding 86% to